Patent · US Active

Incontinence therapy

US9724511B2 · kind B2 · utility

26Cited by
18References
29Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 2, 2016
Grant dateAug 8, 2017
Priority date
Expiry dateSep 2, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61N1/37252
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

Techniques for managing urinary or fecal incontinence include delivering a first type of therapy to generate a first physiological response and, upon detecting a trigger event, delivering a second type of therapy to generate a second physiological response. The first type of therapy can be delivered on a substantially regular basis, while the second type of therapy is delivered as needed to provide an additional boost of therapy. The trigger event for activating the delivery of the second type of therapy may include input from a sensor that indicates a bladder condition, patient activity level or patient posture, or patient input. In some examples, the therapy is stimulation therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.